Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity
La informacin publicada no constituye recomendacin mdica, prescripcin, indicacin teraputica, diagnstico, tratamiento ni invitacin al uso humano
If Eli Lilly files for FDA approval in 2026 and the process runs smoothly, MHRA authorisation could follow by late 2027 or early 2028
Comment Good product Advantages Its been seven day to use
If you are pregnant, breastfeeding, taking prescription medication or under medical supervision it is advisable to consult a GP prior to taking any supplements
Pharmacol Ther 239: 108277
US$ 22.08
US$ 23.72
US$ 21.55
US$ 21.44
US$ 25.22
US$ 25.66
US$ 29.56
